Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Chronic Disease Care With PatientSite
Brief Summary: The overall goal of this randomized, controlled trial is to test whether educational interventions - directed toward empowering patients and delivered via the Beth Israel Deaconess Medical Center (BIDMC's) secure patient Internet portal PatientSite - can improve the outcomes and satisfaction with care of adult primary care patients with 3 common conditions: chronic pain, depression, and progressive difficulty walking.


Options:
A: Arm Label: mebeverine + no website; Type: ACTIVE_COMPARATOR; Interventions: Drug: mebeverine, Behavioral: No website | Arm Label: methylcellulose + no website; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylcellulose, Behavioral: No website | Arm Label: placebo + no website; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Behavioral: No website | Arm Label: mebeverine + CBT website minimal support; Type: ACTIVE_COMPARATOR; Interventions: Drug: mebeverine, Behavioral: CBT website with minimal support | Arm Label: methylcellulose + CBT website; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylcellulose, Behavioral: CBT website with minimal support | Arm Label: placebo + CBT website minimal support; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Behavioral: CBT website with minimal support | Arm Label: mebeverine + CBT website with support; Type: ACTIVE_COMPARATOR; Interventions: Drug: mebeverine, Behavioral: CBT website with support | Arm Label: methylcellulose + CBT website support; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylcellulose, Behavioral: CBT website with support | Arm Label: placebo + CBT website with support; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Behavioral: CBT website with support | Intervention Type: DRUG; Name: mebeverine; Assigned to Arm(s): mebeverine + CBT website minimal support, mebeverine + CBT website with support, mebeverine + no website | Intervention Type: DRUG; Name: methylcellulose; Assigned to Arm(s): methylcellulose + CBT website, methylcellulose + CBT website support, methylcellulose + no website | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo + CBT website minimal support, placebo + CBT website with support, placebo + no website | Intervention Type: BEHAVIORAL; Name: CBT website with support; Assigned to Arm(s): mebeverine + CBT website with support, methylcellulose + CBT website support, placebo + CBT website with support | Intervention Type: BEHAVIORAL; Name: No website; Assigned to Arm(s): mebeverine + no website, methylcellulose + no website, placebo + no website | Intervention Type: BEHAVIORAL; Name: CBT website with minimal support; Assigned to Arm(s): mebeverine + CBT website minimal support, methylcellulose + CBT website, placebo + CBT website minimal support
B: Intervention Type: BEHAVIORAL; Name: E-mail coaching to improve patient communication with doctor; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A
D: Intervention Type: PROCEDURE; Name: management of therapy complications; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: pain therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A

Answer: B